Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.11 - Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
10:05 - 10:15 | Presenter: Baohui Han | Author(s): Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, jialin Qian, Yuchen Han
- Abstract
Loading... -
+
JCSE01.15 - Liver Metastases Predicts Poorer Prognosis in Advanced NSCLC Patients Who Receiving Nivolumab Monotherapy
10:45 - 10:45 | Presenter: Guowei Zhang | Author(s): Ruirui Cheng, Huijuan Wang, Zhiyong Ma
- Abstract
Loading... -
+
JCSE01.20 - Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
10:45 - 10:45 | Presenter: Qian Chu | Author(s): Wei Zhang, Xun Yuan, Xue Wang, Shanshan Huang, Jingyao Tu, Fangfang Liu, Jin Li, Jing Li, Yuan Chen
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.03 - A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
15:35 - 15:45 | Presenter: Caicun Zhou | Author(s): Gongyan Chen, yunchao Huang, Jianying Zhou, LiZhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu, Yiping Zhang, Yueyin Pan, Jun Zhao, LiPing Wang, Jianhua Chang, Qun Chen, Xiubao Ren, Wei Zhang, Yun Fan, Zhiyong He, Jian Fang, Kangsheng Gu, Xiaorong Dong, Faguang Jin, Hongjun Gao, Guangyu An, Cuimin Ding, Xiaodong Jiang, Jianping Xiong, Xiangdong Zhou, Sheng Hu, Ping Lu, Anwen Liu, Shuliang Guo, Jianjin Huang, Chengchu Zhu, Jian Zhao, Beili Gao, Yinglan Chen, Chengping Hu, Jian Zhang, Hongmei Zhang, Hui Zhao, Yujie Zhou, Yanfei Tai
- Abstract
Loading...
-
+
EP1.01 - Advanced NSCLC
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
EP1.01-65 - The Relationship Between Preliminary Efficacy and Prognosis After First-Line EGFR-TKI Treatment of Advanced NSCLC
08:00 - 08:00 | Presenter: Yanwei Zhang | Author(s): Dongfang Chen, Tianqing Chu, Qing Chang, Liwen Xiong, Rong Qiao, Jiajun Teng, Baohui Han, Runbo Zhong
- Abstract
Loading...
-
+
EP1.03 - Biology
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
EP1.03-11 - Mechanisms of Gefitinib Plus Pemetrexed on Human Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Yuqing Lou | Author(s): Jianlin Xu, Yanwei Zhang, Jun Lu, Xueyan Zhang, Huimin Wang, Wei Zhang, Baohui Han
- Abstract
Loading... -
+
EP1.03-12 - IL-10 Promotes Tumor Aggressiveness in Non-Small Cell Lung Cancer via Down-Regulated the Expression Level of miR-125b
08:00 - 08:00 | Presenter: Yanwei Zhang | Author(s): Baohui Han
- Abstract
Loading... -
+
EP1.03-19 - The Frequency and Prognosis of MDM2 Mutations in East Asian Non-Small-Cell Lung Cancer Patients
08:00 - 08:00 | Presenter: Chunwei Xu | Author(s): Bing Wan, Wenxian Wang, Xiuwei Zhang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Zhangzhou Huang, Gang Chen, Meiyu Fang, Tangfeng Lv, Yong Song
- Abstract
Loading... -
+
EP1.03-22 - Prognostic Value of Serum Inflammation Biomarkers in Early Stage Lung Adenocarcinoma
08:00 - 08:00 | Presenter: Yanwei Zhang | Author(s): Minjuan Hu, Baohui Han
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-95 - Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
09:45 - 09:45 | Presenter: Tianqing Chu | Author(s): Baohui Han, Xueyan Zhang, Hua Zhong, Bo Zhang, Huimin Wang, Aiqin Gu, Wei Zhang, Chunlei Shi, Runbo Zhong
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-02 - Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Baohui Han | Author(s): Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, jialin Qian, Yuchen Han
- Abstract
Loading... -
+
P1.04-68 - Liver Metastases Predicts Poorer Prognosis in Advanced NSCLC Patients Who Receiving Nivolumab Monotherapy
09:45 - 09:45 | Presenter: Guowei Zhang | Author(s): Ruirui Cheng, Huijuan Wang, Zhiyong Ma
- Abstract
Loading...
-
+
P1.09 - Pathology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Pathology
-
+
P1.09-23 - A33 and SATB2 Immunohistochemistry for Differentiating Metastatic Colorectal Carcinoma from Pulmonary Enteric Adenocarcinoma
09:45 - 09:45 | Presenter: Likun Hou | Author(s): Chunyan Wu, Wei Zhang, Junhong Guo
- Abstract
Loading...
-
+
P1.13 - Staging
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Staging
-
+
P1.13-03 - Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype
09:45 - 09:45 | Presenter: Yaxing Shen | Author(s): Ting Ye, Lin Deng, Shengping Wang, Jiaqing Xiang, Yawei Zhang, Hong Hu, Yihua Sun, Yuan Li, Lei Shen, Li Xie, Wenchao Gu, Yue Zhao, Fangqiu Fu, Weijun Peng, Haiquan Chen
- Abstract
Loading...
-
+
P1.17 - Treatment of Early Stage/Localized Disease
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
-
+
P1.17-05 - What Is the Optimal Number of Examined Lymph Node in Stage IA Non-Small Cell Lung Cancer?
09:45 - 09:45 | Presenter: Yuan Chen | Author(s): Liu Huang, Vanisha Chummun, Wei Zhang, Qian Chu
- Abstract
Loading...
-
+
OA11 - Decomplexifying Molecular Targets, Immunotherapy and Treatment Settings in the Real World
- 14:00 - 15:30
- 9/09/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Moderators:Kumar Prabhash, Jyoti D Patel
-
+
OA11.07 - Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for EGFR Mutation NSCLC Patients: Update Data for NCT02148380
15:05 - 15:15 | Presenter: Wei Zhang | Author(s): Jianlin Xu, Yuqing Lou, Yanwei Zhang, Baohui Han
- Abstract
Loading...